No Recent News for the Company
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
20-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Cian Healthcare Ltd |
| 2 | CIN NO. | L24233PN2003PLC017563 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 13.55 |
| 4 | Highest Credit Rating during the previous FY | NA |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No
Name of the Company Secretary: Rachit Malhotra
Designation: Company Secretary and Cheif Complaince Officer
EmailId: cs@cian.co
Designation: Company Secretary and Cheif Complaince Officer
EmailId: cs@cian.co
Name of the Chief Financial Officer: Kalyani Vijay Chordia
Designation: Cheif Fianancial Officer
EmailId: cs@cian.co
Designation: Cheif Fianancial Officer
EmailId: cs@cian.co
Date: 20/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
14-Apr-2026 | Source : BSEAs per the Disclosure attached.
Update On The Receipt Of The Trading Approval For The 25000000 (Two Crores Fifty Lakhs) Fully Paid-Up Equity Shares At A Face Value Of INR 10/- (Indian Rupees Ten Only) Each To The Public Shareholders And Promoters.
31-Mar-2026 | Source : BSEAs per the Disclosure attached.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






